MAIN MENU

BACK

BACK

  • Home

  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
Explore PAREXEL
  • JourneyGO
  • SolutionsGO
  • ExperienceGO
  • Outsourcing ModelsGO
  • Planning
  • Phase I
  • Phase IIa
  • Phase II-III
  • Phase IIIb-IV
  • Post Launch
  • Clinical Research
    • Early Phase Services
      • Dedicated Therapeutic Expertise
        • Early Phase and Late Phase integrated study management
      • Patient Populations
      • Strategic Locations
        • Berlin
          • Virtual Tour
        • London
          • Virtual Tour
        • Baltimore
          • Facility
          • Virtual Tour
        • Los Angeles
          • Virtual Tour
        • Bloemfontein
          • Facility
          • Virtual Tour
      • Phase 1, First in Human
        • Ethnobridging for Accelerated Global Drug Development
      • Phase IIa, Proof of Concept
      • Early Product Development
      • Ethnobridging
      • Clinical PK/PD and Pharmacometrics Services
        • Case Study: Safety/Pharmacovigilance #1
        • Case Study: Safety/Pharmacovigilance #2
      • Bioanalytical and Biomarkers
      • Bioequivalence Studies
      • Volunteer to Participate
    • Phase II-III Services
      • Phase III
        • Case Study: Chronic Renal Failure
        • Case Study: Expanded Access Program
        • Case Study: Accelerating development in global COPD trials
      • Medical Writing and Submission
      • Feasibility and Enrollment
        • Patient Recruitment
          • Case Study: Pediatric Migraine Patient Recruitment
        • Country and Site Selection
        • Alliance Site Strategy
        • Protocol Optimization
    • Phase IIIb-IV
    • ForeSite™ Clinical Trial Methodology
      • Study Design
      • Study Start-Up
      • Study Execution
    • Global Data Operations
      • Clinical Data Management
      • Biostatistics Services
      • Clinical MetaData Repository (MDR)
    • Quantitative Clinical Development Services
    • Clinical Trial Supplies & Logistics
      • Global Reach
      • Clinical Trial Supplies
      • Ancillary Supplies
      • Laboratory Logistics and Biological Sample Lifecycle Management Services
      • Randomization and Trial Supply Management
      • Cold Chain Logistics
      • Clinical Trial Supply Chain - Active Tracking
    • Customer Care Services
    • Genomic Medicine Services
    • Clinical Adjudication Services
  • Informatics
    • Perceptive® Cloud
    • Study Management and Monitoring
      • IMPACT® CTMS Software
      • IMPACT® CTMS Support
      • IMPACT® Progress
      • IMPACT® MySites
      • IMPACT® Investigator
      • IMPACT® Payments
      • IMPACT® Clinical Supplies Tracking
      • Data-Driven Monitoring
        • Clinical Leader Interview with Camie Briton
      • Combined EDC-RTSM
      • Integration Services
      • MyTrials® Analytics
    • Electronic Data Capture
      • DataLabs® EDC
        • EDC ranked highest in customer satisfaction
        • Taking the Pain out of EDC Deployment
      • DataLabs® EDC Training
    • Randomization and Trial Supply Management
      • ClinPhone® RTSM for Early Phase
      • ClinPhone® RTSM for Phase II/III
        • Faster implementation of RTSM (a.k.a. IRT) systems
        • Drug Accountability
        • Reporting Solutions
      • ClinPhone® RTSM for Peri/Post-Approval
      • ClinPhone® RTSM for Asia-Pacific
      • Clinical Trial Supplies & Logistics
      • Clinical Trial Supply Chain - Active Tracking
      • ClinPhone RTSM Mobile App
    • Medical Imaging
      • Therapeutic Expertise
        • Oncology Imaging Expertise
          • Criteria Experience
            • 1996 NCI-WG CLL
            • IWCLL 2008
              • Key Topics: IWCLL 2008
                • Definitions
                • Usable Criteria to Evaluate
                • Target Sites of Disease
                • Non-Target Sites of Disease
                • Organomegaly
                • New Lesions
                • B symptoms
                • Blood Counts
                • Bone Marrow
                • Transformation
                • Role of Imaging in CLL Clinical Trials
                • Clinical Data Assessments
            • 1999 IWG-NHL
            • 2007 IWG-NHL
              • Key Topics: 2007 IWG-NHL Assessment Criteria
                • Definitions
                • Usable Criteria to Evaluate
                • Target Sites of Disease
                • Non-Target Sites of Disease
                • Organomegaly
                • New Lesions
                • Bone Marrow
                • Other Laboratory Values and Symptoms
                • Incorporation of FDG-PET
                • Defining Normal, Abnormal and Measurable
                • Problem with CRu
            • RECIST
        • Neurology Imaging Expertise
        • Musculoskeletal (MSK) Imaging Expertise
        • Women's Health Imaging Expertise
        • Dermatology Imaging Expertise
        • Gastroenterology Imaging Expertise
        • Ophthalmology Imaging Expertise
        • Volumetric Imaging Expertise
        • Cardiovascular Imaging Expertise
      • Imaging Services
      • Scientific Advisors
      • Consultation
      • Advanced Medical Imaging
        • Cloud-Based Solutions for Sites
    • Patient Sensors
    • Regulatory Information Management
      • LIQUENT InSight®
      • Regulatory Cloud
      • Regulatory Outsourcing Services
    • Customer Care Services
    • PAREXEL's Education Services
      • IMPACT® CTMS Training
      • LIQUENT InSight® Training
        • Courses & Registration
          • LIQUENT InSight® for Submission Management
            • LIQUENT InSight®Submission Planning and Tracking
          • LIQUENT SmartDesk™
            • Automating the Publishing Process with LIQUENT SmartDesk™ for PDF
          • LIQUENT InSight for Viewing
            • Reviewing Submissions with LIQUENT InSight® for Viewing
        • Training Resources
      • DataLabs® EDC Training
      • Perceptive MyTrials® Training
      • Data-Driven Monitoring Training
      • Certification Programs
      • Other Training Services
    • Electronic Clinical Outcome Assessments (eCOA)
      • ePRO (electronic Patient Reported Outcomes)
      • Clinical Outcome Assessments Consulting
    • Asset Transfer Services
  • Consulting
    • Integrated Product Development
      • A Biosimilar Milestone with Implications
    • Regulatory Compliance & Risk Management
      • Q&A about GCP
        • Quality By Design Putting Theory Into Practice
      • Strategic Compliance: Data Integrity
      • FDA 483s: Your Questions Answered
      • Important Reminder About PET (Positron Emitting Topography) FDA Regulations
      • Quality By Design Putting Theory Into Practice
    • Regulatory Outsourcing Services
      • eCTD
    • Regulatory Information Management & IDMP Solutions
      • IDMP Readiness Assessment
      • IDMP Task Force Updates
        • November 2015 Task Force Meeting
    • Market Access Consulting
  • Access
    • Real World Evidence
      • Late Phase Clinical Operations
        • Late Phase Interventional Trials
        • Observational Research
        • Epidemiology
        • Expanded Access Programs
        • Clinical Outcome Assessment (COA)
          • Case Study: Health Economics
          • Outcomes Research
      • Real World Data Services
    • Drug Safety Services
      • Risk Management / REMS
    • Market Access Consulting
      • Commercial Decision Pathways
      • Evidence Generation
        • Evidence Review and Meta-Analysis
          • Evidence Review Options
          • Evidence Review Resources
        • Health Economic Modeling
        • Global and AMCP Value Dossiers
        • Manuscripts and Posters
        • Data Analytics
        • Strategic Communications
      • Access Realization
        • Pricing, Reimbursement and Market Access Expertise
        • List of Services: Pricing, Reimbursement and Market Access
      • Market Access and HUB Services
    • Medical Communications
      • Communication Strategy
      • Publications Planning and Scientific Content
      • Expert Identification and Engagement
      • Global Study Engagement
      • Branding and Creative Strategy
      • Digital Media and Video Solutions
      • Live and Virtual Events
      • Payer Communication
      • Editorial and Production
    • Outsourced Field-Based Medical Teams
  • Therapeutic Expertise
    • Oncology
    • Cardiovascular & Metabolic Diseases
    • Central Nervous System (CNS) Disorders
    • Infectious Disease
    • Respiratory Capabilities
    • Rheumatology & Immunology Capabilities
    • Rare Diseases
  • Industry Expertise
    • Pharmaceuticals
      • Biosimilar Consulting
    • Medical Devices
    • Biologics
    • Biosimilars
      • Biosimilar Video
  • Regulatory Expertise
  • Market Access Expertise
  • Global Presence
    • North America
    • South America
    • Europe
    • Asia
    • Middle East & Africa
    • Emerging Markets
  • Strategic Partnerships
  • ExecuPharm Functional Service Solutions
  • PAREXEL® BioPharm Unit
  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
  • Journey
    • Planning
    • Phase I
    • Phase IIa
    • Phase II-III
    • Phase IIIb-IV
    • Post Launch
  • Solutions
    • Clinical Research
      • Early Phase Services
      • Phase II-III Services
      • Phase IIIb-IV
      • ForeSite™ Clinical Trial Methodology
      • Global Data Operations
      • Quantitative Clinical Development Services
      • Clinical Trial Supplies & Logistics
      • Customer Care Services
      • Genomic Medicine Services
      • Clinical Adjudication Services
    • Informatics
      • Perceptive® Cloud
      • Study Management and Monitoring
      • Electronic Data Capture
      • Randomization and Trial Supply Management
      • Medical Imaging
      • Patient Sensors
      • Regulatory Information Management
      • Customer Care Services
      • PAREXEL's Education Services
      • Electronic Clinical Outcome Assessments (eCOA)
      • Asset Transfer Services
    • Consulting
      • Integrated Product Development
      • Regulatory Compliance & Risk Management
      • Regulatory Outsourcing Services
      • Regulatory Information Management & IDMP Solutions
      • Market Access Consulting
    • Access
      • Real World Evidence
      • Drug Safety Services
      • Market Access Consulting
      • Medical Communications
      • Outsourced Field-Based Medical Teams
  • Experience
    • Therapeutic Expertise
      • Oncology
      • Cardiovascular & Metabolic Diseases
      • Central Nervous System (CNS) Disorders
      • Infectious Disease
      • Respiratory Capabilities
      • Rheumatology & Immunology Capabilities
      • Rare Diseases
    • Industry Expertise
      • Pharmaceuticals
      • Medical Devices
      • Biologics
      • Biosimilars
    • Regulatory Expertise
    • Market Access Expertise
    • Global Presence
      • North America
      • South America
      • Europe
      • Asia
      • Middle East & Africa
      • Emerging Markets
  • Outsourcing Models
    • Strategic Partnerships
    • ExecuPharm Functional Service Solutions
    • PAREXEL® BioPharm Unit
  • Company
    • Management Team
      • Josef H. von Rickenbach
      • Mark A. Goldberg, M.D.
      • Roland Andersson, Ph.D.
      • Michael Crowley
      • Xavier Flinois
      • Michele Fournier
      • David J. Godwin
      • Simon Harford
      • Sy Pretorius, M.D.
      • Gadi Saarony
      • Joshua Schultz
    • News & Events
      • Press Releases
      • Events
      • Webinars
      • 12th Annual Partnerships in Clinical Trials Congress
      • Archived PAREXEL in the News
    • Find an Office
    • Careers
      • Careers at PAREXEL®
      • CEO Message
      • Find Your Path - Opportunities
      • University Graduates – Opportunities for students
    • Volunteer
      • About Us
      • Locations Worldwide
      • About Clinical Trials
      • Why Participate?
      • FAQs
      • Glossary
    • Sustainability
      • Consumption Trend Analysis
    • Code of Conduct
    • eClinical Innovation
    • Purchasing
      • Purchase Order Terms and Conditions
      • Bedingungen für den Kaufauftrag
      • Vigente desde el
      • PO Terms - Japanese
      • PO Terms - Chinese 'S'
      • PO Terms - Chinese 'T'
      • Ordem de Compra Termos e Condições
    • Contact Us
      • Thank You
    • Partners
      • Service Partners
      • Training Partners
      • Technology Partners
      • Referral Partners
      • Accredited Partner Program
  • Perceptive®
  • User Group Meeting
    • IMPACT CTMS User Group Meeting Details and Agendas
    • IMPACT CTMS User Group Meeting Justification Letter
    • Meeting Registration and Hotel Details
    • Benefits for attending the IMPACT CTMS User Group Meeting
    • Registration Rates
    • Hotel Rates
  • Horizons
    • About
    • Locations
    • FAQs
    • Agenda
  • RWE Symposia
    • About
    • Locations
    • FAQs
    • Agenda
  • Graduate | PAREXEL
    • Culture at PAREXEL
    • Former Trainees at PAREXEL
      • Career Trainee Meghan
      • Career Trainee Sam
    • Great Place to Work
    • PAREXEL Overview
    • Clinical Trainee Program Belgium
    • Clinical Trainee Program Japan
    • Graduate Scheme India
    • Clinical Research Awards
    • Graduate Scheme UK - Open House Event on 21st Feb 2018
  • parexel-insights
    • This Disease Will Not Win the Fight
    • Imaging Endpoint Selection For Biosimilar Development
    • Why RTSM & IRT stand for Speed, Simplicity & Service
    • Best Practices to Improve the IRT Site User Experience
    • Life is Short and Love is Eternal
    • How Performance Reviews Support High-Performance Talent
    • Three Keys To Mitigating Risk In Adaptive Trials
    • Dream or Reality- Improving Patient Safety & Reducing Costs?
    • Attitude is Everything
    • Genomic Medicine, Data Modeling and Clinical Trials
    • Dragons - the Guardians of Disease
    • Drew Garty Discusses Data Driven Monitoring
    • Anything is Possible
    • Wearables Shaping the Future of Clinical Trials
    • How to Know You’re Keeping Your (Clinical Trial Supplies) Cool
    • Surveillance or Surgery?
    • "Yes, I Can!"
    • Albert Liou Discusses the Drug Development Landscape in Korea
    • Effective Late Stage Pathways For Biosimilar Products
    • Adaptive Trials: Complex But Advantageous
    • If You Never Stop Learning, You Can Never Stop Earning
    • How to Simplify Site Tasks and Help Ensure Dispensing Accuracy
    • Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies
    • Active Tracking Is Out To Reduce Sites’ Workload
    • Mark A. Goldberg, President & COO, Discusses PAREXEL’s Acquisition of Quantum Solutions India (QSI)
    • Albert Siu, PhD, Explains How PAREXEL Academy Benefits Clients
    • Biosimilar mAbs – a unique and distinct market (for the time being…?)
    • Ubavka DeNoble Talks About PAREXEL's BioPharm Unit
    • Clarifying the Criteria that Better Capture Antitumor Activity of Immune Therapeutics
    • How Protocol Optimization Improves Clinical Trial Outcomes
    • PAREXEL’s Training Approach and the Importance of Training a Global Workforce
    • Dr. Sy Pretorius, Chief Scientific Officer Talks About Adaptive Design Trials
    • Want Your Business to Thrive? Focus on Developing Your People
    • How do eClincal solutions Increase Clinical Trial Efficiency?
    • Clinical Trial Support Query - Who Ya Gonna Call?
    • 30 Years Later: Lessons from Living in a Pandemic
    • PAREXEL's Connected Journey™ of Data-Driven Services
    • Clinical Trial Feasibility & Patient Enrollment: Differentiation Through Innovation
    • Quantitative Modeling For Clinical Trials
    • Innovation in the Pharmaceutical Industry: A Change Toward Personalized Medicine
    • A Biosimilar Milestone with Implications
    • Medical Writing for Submission to Asia-Pacific Regulatory Authorities
    • Grateful for Advancements in Medicine
    • The Complete Journey: Improving Clinical Trials Using Modern Technology
    • HOW TO EFFECTIVELY DEVELOP CLINICAL DOCUMENTS IN THE EU/US AND CHINA NDA DOSSIER
    • CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE
    • World Cancer Day: Reflecting on Progress and Hope for Patients
    • Demonstrating Value and Managing Risk Throughout Development
    • Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
    • Navigating Regulatory Complexities Of Biosimilar Development
    • World Cancer Day: Breakthroughs and Challenges for Precision Medicine
    • The Clinical, Regulatory and Commercial Implications of Rapid Approval
    • Overcoming Data Capture and Management Challenges
    • 3 Principles for a Sound Clinical and Regulatory Document Strategy for Small Biopharmaceuticals
    • How to Maximize Potential and Sidestep Pitfalls of MAPs
    • The Collaborative Advantage of Biopharma Companies and Global Service Providers
    • So, My Fitbit is Clinical Trial Grade Right?
    • Successfully Integrating Electronic Health Record and Electronic Data Collection Data
    • Improving Site Experience with Risk-Based Monitoring
    • The Emerging Role of Wearable Devices For Real-World Data Collection
    • Trends in Translational Development
    • Immuno-Oncology: Past, Present and Future
    • Aligning on Patient Outcomes – How Market Dynamics Can Facilitate RWD (Real World Data) Solutions in Research
    • The Evolution of Drug Development & Market Access via Connected Data-driven Solutions
    • You’re Hot Then You’re Cold -Temperature Management & RTSM Integration
    • Contracting - A Key Component Of A Strong Vendor Relationship
    • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development
    • Driving the Digital Transformation of the Industry
    • Regulatory Strategy In Emerging Markets
    • High Performance Workplace Practices That Attract and Retain Millennials
    • Developing Drugs in the New Era of Personalized Medicines
    • Orphan Drug Pricing in Europe
    • Clinical Development of Next Generation Biologics
    • Progress in Pursuit of a Cure - World AIDS Day 2017
    • Key Considerations In Biologics Clinical Development
    • Increasing Study Predictability
    • On Demand Webinar - The Power of Foresight: Improving Drug Development Performance through Optimized Protocol Design
    • What You Need To Know About Biosimilars Development
    • Mergers & Acquisitions: Where’s the Real Finish Line?
    • Leveraging the Cloud to Accelerate Time to Treatment
    • WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?
    • Recorded Webinar: Getting to Approval Faster Through Technology Innovation
    • Navigating Regulatory Submissions
    • Data Management Roles, Process and Technologies in Risk Based Study Execution
    • Latin America’s Role in Clinical Studies
    • Interview with PAREXEL’s Aida Sabo, About Challenges & Successes in Diversity & Inclusion
    • Why Strategy is Not Enough: Building the Bridge From Strategy to Results Requires Organizational Excellence
    • The Impact of the Digital Human Resources Organization on People - Part 1
    • Effective use of Value to Achieve Optimal Market Access
    • Utilizing Secondary Healthcare Data Assets
    • Optimizing the clinical development process with Social, Mobile, Analytics, and Cloud (SMAC)
    • Training Compliance is an Increasingly Complex Journey
    • Beyond Diversity: What Happens When You Define a Culture of Inclusion
    • The Next Generation of Talent Management: Opportunities For Diversity
    • Get Into Pole Position with Modern IRT Services
    • When It Comes to CTMS One Size Does Not Fit All
    • Protocol Optimization
    • Focused on the Finish Line
    • Designing Trials Payers Can Trust
    • Using Analytics to Optimize The Clinical Development Process
    • Running with a Purpose
    • The Human Touch: Aligning Reward Systems with Company Strategy and Meaningful Work
    • Diversity and Inclusion: This Is How the Best Global Companies Learn, Plan, and Measure Success
    • Shogo Nakamori Discusses Joint Program for Clinical Research
    • Rooting for Team Jessie
    • Working Towards a Glimpse of a Cure
    • Accelerated Pathways and Stock Prices
    • Josh Schultz, Corp. VP Talks About PAREXEL Access
    • Accelerated Pathways & Commercial Consequences Forum & Findings
    • Something Good Always Comes From Something Bad
    • New Approaches to Data Management in Clinical Trials
    • Accelerated Pathways: Global Opportunities & Challenges for Innovators
    • The Journey Continues – I Got This
    • Shogo Nakamori Discusses Japan & Multi-national Trials
    • Shogo Nakamori Discusses Trends in Drug Development in Japan
    • When the Doctor Becomes the Patient
    • 'Now is the time to include Japan' says PAREXEL
    • Recognizing Uncle David
    • Involved & Engaged: The Last Mile of Business Performance
    • A People Strategy Attracts the Best Talent
  • agile-IRT
    • Agile IRT
    • Reduced Timelines
    • Simpler Processes
    • Expert Services
    • Contact
  • test
    • Graduate | PAREXEL
  • Menu
Home

THE CONNECTED JOURNEY™ OF DATA-DRIVEN SERVICES

Watch the video

Read Brochure


Inside PAREXEL:

Introducing Perceptive® Cloud

Intelligent Technology

Part of The Connected Journey™, the Perceptive Cloud combines our extensive industry expertise and innovative technology solutions with the power of Microsoft's proven cloud service. LEARN MORE >


Inside PAREXEL:

The Connected Journey™ of Data-Driven Services

Data-Driven Insights

See how our commitment to informing our client conversations with the best possible insights, leads to better decisions that simplify the journey. WATCH VIDEO


Inside PAREXEL:

The Connected Journey™ of Data-Driven Services

Real World Data Services

Today, real world data is critical at every step of the journey to market, and our clients count on us to help analyze the right data to uncover the most valuable insights. WATCH VIDEO


Inside PAREXEL:

The Connected Journey™ of Data-Driven Services

Analytics and Technology

Industry-wide change is happening. See how we’re leading the way with PAREXEL® Analytics, our integrated technology platform. WATCH VIDEO

 
 

Journey

Solutions

Experience

Outsourcing Models

  • Journey
  • Solutions
  • Experience
  • Outsourcing Models
Explore More
X

The first steps of any journey include choosing the smartest route to your destination. To do that well, start by choosing the industry leadership and global resources of PAREXEL.

- Explore Planning
Explore More
X

To simplify your journey from new molecules to new medications, start with a partner who’ll be beside you at every step with expertise, technologies, and facilities worldwide.

- Explore Phase I
Journey1
Explore More
X

By accelerating your access to the right patients and expertise for your journey, we accelerate your access to the efficacy data you need to persuade key stakeholders.

- Explore Phase IIa
Explore More
X

While our strategic expertise, global resources, and clinical logistics speed pivotal trials, our eClinical technologies and regulatory insights cut your costs, risks, and delays.

- Explore Phase II-III
Explore More
X

As you approach your NDA submissions, having a technologically advanced, integrated late phase team with global and local insight to steer you through is crucial.

- Explore Phase IIIb-IV
Explore More
X

After all the science, trials, and paperwork, how far your new drug will go depends on its use in the real world. PAREXEL's world class post-launch team can take your further.

- Explore Post Launch
Explore More
X

Partner with PAREXEL throughout your journey for more clinical expertise, regulatory insights, dedicated trial sites, and quality patients. All with less cost and fewer delays.

- Explore Clinical Research
Explore More
X

PAREXEL's advanced, integrated eClinical and regulatory technology platforms expedite your journey, improve data tracking, and cut costs at every phase, end-to-end.

- Explore Informatics
Explore More
X

Your new drug's journey to market will go more smoothly with PAREXEL's mastery of efficacy results, regulations, reimbursement, and market access beside you.

- Explore Consulting
Explore More
X

A unique, simplified and complete solution that can help identify, generate, evaluate and communicate the evidence of product value.

- Explore Access
Explore More
X

You create your new discovery to treat today's worst medical conditions. PAREXEL has the oncology, CNS, cardiovascular, respiratory, and other medical expertise you need in a partner.

- Explore Therapeutic Expertise
Explore More
X

PAREXEL has some of the most experienced, most talented minds worldwide finding solutions to keep our biopharmaceuticals and medical device clients on course from beginning to end.

- Explore Industry Expertise
Explore More
X

A global footprint is common in today’s biopharmaceuticals industry. But PAREXEL has 77 locations in 51 countries, all interconnected in real time and harmonized to the same SOPs.

- Explore Global Presence
Explore More
X

Your path to a successful new drug will hit many regulatory hurdles. Our top regulatory experts and technologies optimize trial data, ease filings, and keep you moving ahead.

- Explore Regulatory Expertise
Explore More
X

Let PAREXEL's commercialization experts analyze market potential, health sector impacts, payer coverages, and more to secure crucial first market access for your new drug.

- Explore Commercialization Expertise
Explore More
X

The PAREXEL® BioPharm Unit delivers innovative solutions to help small to mid-sized companies expand their in-house expertise, support internal decision-making and position themselves among industry leaders.

- Explore the PAREXEL® BioPharm Unit
Explore More
X

ExecuPharm Functional Service Solutions supplies a full-range of functional resources, management, processes and easy to use tracking systems for any clinical study.

- Explore Functional Services
Explore More
X

PAREXEL’s Strategic Partnerships are a more collaborative and operationally efficient relationship allowing you to reach your drug development milestones faster and smarter.

- Explore Strategic Partnerships
  • Video Highlights
  • PAREXEL Insights
  • News & Events
  • Highlights
Simplifying Clinical Trial Design and Execution
with PAREXEL®
Inside PAREXEL:
Predictive Modeling
Inside PAREXEL:
Genomic Medicine
Inside PAREXEL:
Protocol Optimization
Utilizing Secondary Data Assets
PAREXEL® Access
Navigating Regulatory Submissions
PAREXEL® Consulting
Increasing Study Predictability
PAREXEL® Clinical Development Optimization
Nothing is Bigger than Your Molecule
PAREXEL® Clinical Research Services
Beginning with the End in Mind
PAREXEL® Clinical, Regulatory and Commercial Consulting
Using Technology to Bring it All Together
PAREXEL® Clinical Trials Technology
PAREXEL's Alberto Grignolo, PhD
Comments on Key Trends at DIA 2015
CONCEPT TO COMMERCIALIZATION
Solving the Complex
PATENT TO PATIENT
The Bigger Journey: Navigating the Human Pathway
GLOBAL FOOTPRINT TO GLOBAL MIND
Capitalizing on Intellectual Capital
More Videos

Medical Writing Services In Asia: Recent Developments And Trends

Read more

Wearables in clinical trials. Where we are and where are we going.

Read more

Parexel debuts Perceptive Cloud, its informatics solutions built on the Microsoft alliance

Read more
December 18, 2017

PAREXEL Announces Enhanced Global Data Operations Offering to Drive Efficiencies for Life Science Companies

December 12, 2017

PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry

November 15, 2017

PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry

Browse by Topic

  • BioPharm Business Trends
  • Data Analytics and Insights
  • Global Drug Development
  • Regulatory and Market Access
  • Talent Management
  • Technology Solutions
  • Workplace and Culture

View All PAREXEL Insights

Latest Insights

World Cancer Day: Breakthroughs and Challenges for Precision Medicine

by Dr. Todd Shuster and Dr. Dana Washburn

Each year on February 4, the world’s population unites in the fight against cancer by recognizing…

Regulatory Strategy In Emerging Markets

by PAREXEL International

Read the presentation Strategy Considerations For Entering Emerging Markets, to learn more about…

You’re Hot Then You’re Cold -Temperature Management & RTSM Integration

by PAREXEL International

You’re Hot Then You’re Cold-Temperature Management & RTSM Integration- learn more in this…

  • Video Highlights
  • X close
    Simplifying Clinical Trial Design and Execution
    with PAREXEL®
    Inside PAREXEL:
    Predictive Modeling
    Inside PAREXEL:
    Genomic Medicine
    Inside PAREXEL:
    Protocol Optimization
    Utilizing Secondary Data Assets
    PAREXEL® Access
    Navigating Regulatory Submissions
    PAREXEL® Consulting
    Increasing Study Predictability
    PAREXEL® Clinical Development Optimization
    Nothing is Bigger than Your Molecule
    PAREXEL® Clinical Research Services
    Beginning with the End in Mind
    PAREXEL® Clinical, Regulatory and Commercial Consulting
    Using Technology to Bring it All Together
    PAREXEL® Clinical Trials Technology
    PAREXEL's Alberto Grignolo, PhD
    Comments on Key Trends at DIA 2015
    CONCEPT TO COMMERCIALIZATION
    Solving the Complex
    PATENT TO PATIENT
    The Bigger Journey: Navigating the Human Pathway
    GLOBAL FOOTPRINT TO GLOBAL MIND
    Capitalizing on Intellectual Capital
    More Videos
  • PAREXEL Insights
  • World Cancer Day: Breakthroughs and Challenges for Precision Medicine

    by Dr. Todd Shuster and Dr. Dana Washburn

    Each year on February 4, the world’s population unites in the fight against cancer by recognizing…

    Regulatory Strategy In Emerging Markets

    by PAREXEL International

    Read the presentation Strategy Considerations For Entering Emerging Markets, to learn more about…

    You’re Hot Then You’re Cold -Temperature Management & RTSM Integration

    by PAREXEL International

    You’re Hot Then You’re Cold-Temperature Management & RTSM Integration- learn more in this…

    View All PAREXEL Insights

  • News & Events
  • December 18, 2017

    PAREXEL Announces Enhanced Global Data Operations Offering to Drive Efficiencies for Life Science Companies

    December 12, 2017

    PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry

    November 15, 2017

    PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry

  • Highlights
  • Medical Writing Services In Asia: Recent Developments And Trends

    Read more

    Wearables in clinical trials. Where we are and where are we going.

    Read more

    Parexel debuts Perceptive Cloud, its informatics solutions built on the Microsoft alliance

    Read more

Linkedin Updates

View Profile
  • PAREXEL experts use a one product, one value proposition approach to ensure compelling product value demonstrations… https://t.co/a1u0nS4vvl
  • Seoul, South Korea takes gold as the top city for clinical trials over the past 5 years. Learn more:… https://t.co/25T7h8QJnD
  • Xavier Flinois, President of PAREXEL Informatics, shares his thoughts on the current state of #wearables in… https://t.co/5PWchfrcux

CAREERS AT PAREXEL®

If you are inspired to make a difference
in the world, we can help you make it possible.

Search job openings worldwide

PAREXEL International Corp.
+1 781 487 9900
195 West Street
Waltham, MA 02451 

  • ABOUT PAREXEL®
  • NEWS & EVENTS
  • VOLUNTEER
  • CONTACT
  • MY PAREXEL PREFERENCE CENTER
  • CLIENT LOGIN
  • LIQUENT®
  • CLINICAL TRIAL INVESTIGATOR
  • SITE MAP
  • TERMS OF SERVICE
  • PRIVACY POLICY
  • EU-U.S. AND SWISS-U.S. PRIVACY SHIELD NOTICE OF CERTIFICATION

Copyright ©2000-2017 PAREXEL International Corporation.